Adequate Use of Cholesterol Lowering Treatment in People With Diabetes
Identifying Attributes
Care Settings
Primary Care
Country
Organisation for Economic Co-operation and Development
Publishing Organisation
Healthcare Quality and Outcomes (HCQO) indicators; Primary Care - Prescribing Indicators
Type of Quality Indicator
Process
IOM Quality Dimension
Safety
Domain
Medications and Medication Management
Defining Attributes
Definition
Percentage of people who are long-term users of glucose regulating medication with concomitant use of one or more prescriptions of cholesterol lowering medication.
Numerator
Number of people who are long-term users of glucose regulating medication (A10B) with concomitant use of ≥ 1 prescription of cholesterol lowering medication.
Denominator
Number of people who are long-term users of glucose regulating medication (A10B) in the prescribing database. Number of people who are long-term users of glucose regulating medication (A10B) are defined as individuals who use >270 Defined Daily Doses (DDD) of A10B per year. If database does not report DDD, derive indicator using >270 days of A10B per year
Exclusions
Use of Risk Adjustment
No
Risk Adjustments
Stratifications
Data Attributes
Type of Data Collection
Administrative data
Data Collection Methods
OECD
Frequency of Data Collection
Annually
Frequency of Data Collection in Days
365
Reporting Methods
Reporting Frequency
Annually
Reporting Frequency in Days
365
Indicator Has Recommended Targets
No
Source and Reference Attributes
Evidence Source
Technical Specifications
Link to Measurement Tools
Quality Indicator Confirmed to be Part of a Program Used to Monitor Quality and Safety of Care Among Older People at a Population-Level between 2012-2022
Yes
Assessed by the Australian Consortium for Aged Care Collaborators as Generally Containing Good Properties (Importance and Scientific Acceptability)
No
Australian Consortium for Aged Care Endorsed
No
Identified by PHARMA-Care Project
No
Upload Date
23 July 2025
Actions
Date Modified 23 July 2025